Several in vitro studies revealed that exogenously added TGF-β1 and TGF-β2 elicit a strong stimulation of migration in a variety ofglioma cells [20–23], while TGF-β gene silencing has shown to reduce glioma cell motility and invasiveness [24]. This evidence concerns the gene TGFB1 and central nervous system cancer.